Precigen (Germany) Performance

I5X Stock  EUR 4.11  0.32  8.44%   
On a scale of 0 to 100, Precigen holds a performance score of 6. The company holds a Beta of -1.29, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Precigen are expected to decrease by larger amounts. On the other hand, during market turmoil, Precigen is expected to outperform it. Please check Precigen's total risk alpha, value at risk, and the relationship between the standard deviation and treynor ratio , to make a quick decision on whether Precigen's historical price patterns will revert.

Risk-Adjusted Performance

Mild

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Precigen are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Precigen reported solid returns over the last few months and may actually be approaching a breakup point. ...more
1
Is Precigen Inc. stock in correction or buying zone - Portfolio Return Report Consistent Income Trade Ideas - newser.com
11/11/2025
2
A Fresh Look at Precigen Valuation Following Q3 Revenue Growth and Widened Net Loss - simplywall.st
11/14/2025
3
Is Precigen Inc. stock supported by strong cash flows - July 2025 Momentum Reliable Intraday Trade Plans - newser.com
11/20/2025
4
Precigen Valuation in Focus After FDA Approval and Strengthened Cash Position - simplywall.st
11/28/2025
5
Sentiment Watch Is Precigen Inc. stock a buy before product launches - July 2025 Action Long Hold Capital Preservation Tips -
12/19/2025
6
Will PGENs New Drug Make a Splash - StocksToTrade
12/29/2025
7
Precigen, Inc. Are Analysts Optimistic - simplywall.st
01/08/2026
8
New expert consensus shifts RRP treatment from surgery to PAPZIMEOS - Stock Titan
01/20/2026
9
Precigen, Inc. Stock Analysis 87 percent Upside Potential Ignites Investor Interest - DirectorsTalk Interviews
01/30/2026
  

Precigen Relative Risk vs. Return Landscape

If you would invest  334.00  in Precigen on November 6, 2025 and sell it today you would earn a total of  77.00  from holding Precigen or generate 23.05% return on investment over 90 days. Precigen is currently producing 0.5001% returns and takes up 5.7631% volatility of returns over 90 trading days. Put another way, 51% of traded stocks are less volatile than Precigen, and 90% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Precigen is expected to generate 7.67 times more return on investment than the market. However, the company is 7.67 times more volatile than its market benchmark. It trades about 0.09 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.11 per unit of risk.

Precigen Target Price Odds to finish over Current Price

The tendency of Precigen Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 4.11 90 days 4.11 
roughly 2.63
Based on a normal probability distribution, the odds of Precigen to move above the current price in 90 days from now is roughly 2.63 (This Precigen probability density function shows the probability of Precigen Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Precigen has a beta of -1.29. This usually indicates as returns on its benchmark rise, returns on holding Precigen are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Precigen is expected to outperform its benchmark. Additionally Precigen has an alpha of 0.4096, implying that it can generate a 0.41 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Precigen Price Density   
       Price  

Predictive Modules for Precigen

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Precigen. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.214.119.87
Details
Intrinsic
Valuation
LowRealHigh
0.163.228.98
Details
Naive
Forecast
LowNextHigh
0.094.3110.08
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.19-0.14-0.1
Details

Precigen Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Precigen is not an exception. The market had few large corrections towards the Precigen's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Precigen, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Precigen within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.41
β
Beta against Dow Jones-1.29
σ
Overall volatility
0.32
Ir
Information ratio 0.05

Precigen Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Precigen for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Precigen can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Precigen is way too risky over 90 days horizon
Precigen appears to be risky and price may revert if volatility continues
Precigen has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 3.92 M. Net Loss for the year was (126.23 M) with loss before overhead, payroll, taxes, and interest of (44.19 M).
Precigen has accumulated about 105.69 M in cash with (68.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.51.
Roughly 72.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: Top mens reebok trainers jd sports Flash Sales JD Sports from JD Sports Health Service Discounts - Through The Fence Baseball

Precigen Fundamentals Growth

Precigen Stock prices reflect investors' perceptions of the future prospects and financial health of Precigen, and Precigen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Precigen Stock performance.

About Precigen Performance

By analyzing Precigen's fundamental ratios, stakeholders can gain valuable insights into Precigen's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Precigen has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Precigen has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland. PRECIGEN INC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 423 people.

Things to note about Precigen performance evaluation

Checking the ongoing alerts about Precigen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Precigen help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Precigen is way too risky over 90 days horizon
Precigen appears to be risky and price may revert if volatility continues
Precigen has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 3.92 M. Net Loss for the year was (126.23 M) with loss before overhead, payroll, taxes, and interest of (44.19 M).
Precigen has accumulated about 105.69 M in cash with (68.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.51.
Roughly 72.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: Top mens reebok trainers jd sports Flash Sales JD Sports from JD Sports Health Service Discounts - Through The Fence Baseball
Evaluating Precigen's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Precigen's stock performance include:
  • Analyzing Precigen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Precigen's stock is overvalued or undervalued compared to its peers.
  • Examining Precigen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Precigen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Precigen's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Precigen's stock. These opinions can provide insight into Precigen's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Precigen's stock performance is not an exact science, and many factors can impact Precigen's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Precigen Stock analysis

When running Precigen's price analysis, check to measure Precigen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Precigen is operating at the current time. Most of Precigen's value examination focuses on studying past and present price action to predict the probability of Precigen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Precigen's price. Additionally, you may evaluate how the addition of Precigen to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios